Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sridhar Mani

Showing results (141-150 of 170) with videos related to

Pageof 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungsGregory A Otterson, Miguel A Villalona-Calero, Sunil Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2012
Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432Patricia M LoRusso, Karthik Venkatakrishnan, Ramesh K Ramanathan, et al.
The Journal of Clinical Investigation|July 13, 2011
Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and miceHongwei Wang, Madhukumar Venkatesh, Hao Li, et al.
Seminars in Oncology|October 3, 2003
Administration of oxaliplatin to patients with renal dysfunction: a preliminary report of the national cancer institute organ dysfunction working groupChris H Takimoto, Scot C Remick, Sunil Sharma, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2005
Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancersRamesh K Ramanathan, Marwan Fakih, Sridhar Mani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of ixabepilone: a first in class epothilone B analogue in late-phase clinical developmentSanjay Goel, Marvin Cohen, S Nilgün Cömezoglu, et al.
Investigational New Drugs|March 1, 2006
Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypesWilliam C Zamboni, Ramesh K Ramanathan, Howard L McLeod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired hepatic function: a National Cancer Institute Organ Dysfunction Working Group studyTimothy W Synold, Chris H Takimoto, James H Doroshow, et al.
The Journal of Biological Chemistry|July 4, 2020
Garcinoic acid prevents β-amyloid (Aβ) deposition in the mouse brainRita Marinelli, Pierangelo Torquato, Desirée Bartolini, et al.
Nature Communications|March 23, 2024
Diindoles produced from commensal microbiota metabolites function as endogenous CAR/Nr1i3 ligandsJiabao Liu, Ainaz Malekoltojari, Anjana Asokakumar, et al.
Pageof 17

Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungsGregory A Otterson, Miguel A Villalona-Calero, Sunil Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2012
Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432Patricia M LoRusso, Karthik Venkatakrishnan, Ramesh K Ramanathan, et al.
The Journal of Clinical Investigation|July 13, 2011
Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and miceHongwei Wang, Madhukumar Venkatesh, Hao Li, et al.
Seminars in Oncology|October 3, 2003
Administration of oxaliplatin to patients with renal dysfunction: a preliminary report of the national cancer institute organ dysfunction working groupChris H Takimoto, Scot C Remick, Sunil Sharma, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2005
Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancersRamesh K Ramanathan, Marwan Fakih, Sridhar Mani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of ixabepilone: a first in class epothilone B analogue in late-phase clinical developmentSanjay Goel, Marvin Cohen, S Nilgün Cömezoglu, et al.
Investigational New Drugs|March 1, 2006
Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypesWilliam C Zamboni, Ramesh K Ramanathan, Howard L McLeod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired hepatic function: a National Cancer Institute Organ Dysfunction Working Group studyTimothy W Synold, Chris H Takimoto, James H Doroshow, et al.
The Journal of Biological Chemistry|July 4, 2020
Garcinoic acid prevents β-amyloid (Aβ) deposition in the mouse brainRita Marinelli, Pierangelo Torquato, Desirée Bartolini, et al.
Nature Communications|March 23, 2024
Diindoles produced from commensal microbiota metabolites function as endogenous CAR/Nr1i3 ligandsJiabao Liu, Ainaz Malekoltojari, Anjana Asokakumar, et al.
Pageof 17